Yang and colleagues analysed the expression of miR-155, regulatory T (Treg) cells (CD4+ CD25+ Foxp3+), and TGF-β in peripheral blood of T2D patients with different severity of DR in comparison with T2D patients not affected by DR and HC [26]. The gene discussed is FOXP3; the disease is type 2 diabetes mellitus.